Cargando…
1-[(6-Chloropyridin-3-yl)methyl]-10-nitro-1,2,3,5,6,7,8,9-octahydro-5,9-methanoimidazo[1,2-a]azocin-5-ol
In the title compound, C(16)H(19)ClN(4)O(3), the cyclohexane ring displays a chair formation and the tetrahydropyridine ring displays an envelope conformation with the methylene C atom as the flap; the imidazolidine ring also displays an envelope conformation with a methylene C atom as the flap...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772455/ https://www.ncbi.nlm.nih.gov/pubmed/24046598 http://dx.doi.org/10.1107/S1600536813014402 |
Sumario: | In the title compound, C(16)H(19)ClN(4)O(3), the cyclohexane ring displays a chair formation and the tetrahydropyridine ring displays an envelope conformation with the methylene C atom as the flap; the imidazolidine ring also displays an envelope conformation with a methylene C atom as the flap. In the crystal, O—H⋯N hydrogen bonds between hydroxy groups and pyridine rings link inversion-related molecules into dimers. Weak C—H⋯O hydrogen bonds further link the dimers into supramolecular chains running along the c axis. |
---|